Celcuity, Inc. 2.75% 01-AUG-2031Celcuity, Inc. 2.75% 01-AUG-2031Celcuity, Inc. 2.75% 01-AUG-2031

Celcuity, Inc. 2.75% 01-AUG-2031

No trades
See on Supercharts

Key facts


Issue date
Aug 1, 2025
Maturity date
Aug 1, 2031
Outstanding amount
‪201.25 M‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
2.75% (Fixed)
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.